EP3634580C0 - Compositions contenant du lactulose permettant de maintenir ou d'améliorer la santé de l'intestin chez l'homme - Google Patents

Compositions contenant du lactulose permettant de maintenir ou d'améliorer la santé de l'intestin chez l'homme

Info

Publication number
EP3634580C0
EP3634580C0 EP18707937.1A EP18707937A EP3634580C0 EP 3634580 C0 EP3634580 C0 EP 3634580C0 EP 18707937 A EP18707937 A EP 18707937A EP 3634580 C0 EP3634580 C0 EP 3634580C0
Authority
EP
European Patent Office
Prior art keywords
lactulose
humans
compositions
maintaining
gut health
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP18707937.1A
Other languages
German (de)
English (en)
Other versions
EP3634580B1 (fr
EP3634580A1 (fr
Inventor
Angelika Kuchinka-Koch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi Austria GmbH
Original Assignee
Fresenius Kabi Austria GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Austria GmbH filed Critical Fresenius Kabi Austria GmbH
Publication of EP3634580A1 publication Critical patent/EP3634580A1/fr
Application granted granted Critical
Publication of EP3634580B1 publication Critical patent/EP3634580B1/fr
Publication of EP3634580C0 publication Critical patent/EP3634580C0/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP18707937.1A 2017-04-28 2018-03-07 Compositions contenant du lactulose permettant de maintenir ou d'améliorer la santé de l'intestin chez l'homme Active EP3634580B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17168700 2017-04-28
PCT/EP2018/055560 WO2018197087A1 (fr) 2017-04-28 2018-03-07 Compositions comprenant du lactulose pour maintenir ou améliorer la santé intestinale chez les êtres humains

Publications (3)

Publication Number Publication Date
EP3634580A1 EP3634580A1 (fr) 2020-04-15
EP3634580B1 EP3634580B1 (fr) 2023-12-20
EP3634580C0 true EP3634580C0 (fr) 2023-12-20

Family

ID=58644949

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18707937.1A Active EP3634580B1 (fr) 2017-04-28 2018-03-07 Compositions contenant du lactulose permettant de maintenir ou d'améliorer la santé de l'intestin chez l'homme

Country Status (3)

Country Link
EP (1) EP3634580B1 (fr)
ES (1) ES2968084T3 (fr)
WO (1) WO2018197087A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11072694B1 (en) * 2021-02-16 2021-07-27 Evoco Limited Biobased compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191295A1 (en) * 2003-03-28 2004-09-30 Locniskar Mary Frances Composition and method for viral inhibition
JP4588403B2 (ja) * 2004-10-04 2010-12-01 森永乳業株式会社 カルシウム・マグネシウム含有組成物の製造方法
US8778907B2 (en) * 2011-04-27 2014-07-15 Cumberland Pharmaceuticals Lactulose for bowel evacuation
CN102871020A (zh) * 2012-10-15 2013-01-16 苏州大学 一种胃肠功能调理营养液及其制备方法
CN104489102B (zh) * 2014-12-26 2017-10-27 光明乳业股份有限公司 一种中老年乳粉及其制备方法

Also Published As

Publication number Publication date
EP3634580B1 (fr) 2023-12-20
WO2018197087A1 (fr) 2018-11-01
ES2968084T3 (es) 2024-05-07
EP3634580A1 (fr) 2020-04-15

Similar Documents

Publication Publication Date Title
IL269642A (en) Methods and preparations to improve health
ZA202000532B (en) Compositions, methods and uses for cleaning, disinfecting and/or sterilizing
HK1248467A1 (zh) 一種植物源類消毒組合物、消毒劑及其製備方法
DK3657954T3 (en) Non-hydrogenated fat composition, use and process
HK1251482A1 (zh) 用於治療補體介導的疾病的組合物和方法
SG11202003261PA (en) Sanitizing compositions and methods for making and using same
HK1257364A1 (zh) 多用途消毒和滅菌溶液的組合物和方法
PL3280423T3 (pl) Kompozycje i sposoby do synergistycznego leczenia glikokaliksu
PT3273947T (pt) Composição para a saúde ocular
IL269743A (en) Methods and preparations for the treatment of disease related to the retina with CCR-3 inhibitor inventions
SG11202009523UA (en) Compositions and methods for long lasting disinfection
SG11202009522TA (en) Compositions and methods for long lasting disinfection
IL290166A (en) Collagen preparations 7 and its use
HK1258999A1 (zh) 用於治療肝臟和維持肝臟健康的組合物、方法和藥物組合物
GB201814745D0 (en) Chromium containing compositions for improving health and fitness
EP3634580C0 (fr) Compositions contenant du lactulose permettant de maintenir ou d'améliorer la santé de l'intestin chez l'homme
PT3106160T (pt) Composição de combinação compreendendo huperzina
DK3573468T3 (en) Fat Composition
PL3347444T3 (pl) Kompozycje tłuszczowe
PL3216452T3 (pl) Kompozycja do zapobiegania lub leczenia zapalenia błony śluzowej zawierająca jako skuteczny składnik NecroX
DK3582624T3 (en) Fat composition
HK1254744A1 (zh) 皮膚消毒用組合物
EP3720449C0 (fr) Composition destinée à être utilisée dans la prévention ou le traitement de la salmonellose
SG11201706369PA (en) Compositions and methods for the treatment of mucositis
IL246608A0 (en) Preparations and methods for treating heart disease

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191127

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
RAX Requested extension states of the european patent have changed

Extension state: BA

Payment date: 20191127

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20201221

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602018062859

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61P0001000000

Ipc: A61K0031140000

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61P0001000000

Ipc: A61K0031140000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/7135 20060101ALI20230627BHEP

Ipc: A61K 31/7016 20060101ALI20230627BHEP

Ipc: A61K 31/66 20060101ALI20230627BHEP

Ipc: A61K 31/375 20060101ALI20230627BHEP

Ipc: A61K 31/203 20060101ALI20230627BHEP

Ipc: A61P 17/00 20060101ALI20230627BHEP

Ipc: A61P 19/00 20060101ALI20230627BHEP

Ipc: A61P 1/00 20060101ALI20230627BHEP

Ipc: A61K 31/14 20060101AFI20230627BHEP

INTG Intention to grant announced

Effective date: 20230712

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602018062859

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

U01 Request for unitary effect filed

Effective date: 20240111

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI

Effective date: 20240122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240321

U20 Renewal fee paid [unitary effect]

Year of fee payment: 7

Effective date: 20240312

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240321

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240304

Year of fee payment: 7

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2968084

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20240507

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240320

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231220